The 9th Vaccine China Leaders Annual Meeting 2024

2024-11-15 14:59

The 9th Vaccine China Leaders Annual Meeting held by Shiyan Life Sciences in 2024 was held as scheduled on October 30, 2024 at 8:30 am at the Grand Hyatt Shanghai Pudong New Area, No. 1199 Yingchun Road.

Organizing Committee Unit of the Conference

Guidance unit:

International Vaccine Institute

Supporting units:

Shanghai Biomedical Technology Industry Promotion Center

Shanghai Food and Drug Safety Research Association

Host:

Shanghai Shiyan Management Consulting Co., Ltd

SHINE CONSULTANT

Shanghai Shiyan Management Consulting Co., Ltd. was established in 2005, dedicated to providing a communication and expert think tank platform for organizational leaders. Through 20 years of accumulation and accumulation, we have covered industries such as finance and investment, transportation and logistics, consumption and tourism, medicine and healthcare, energy and resources, high-tech and telecommunications, public utilities and government, serving the Fortune Global 500 and over 10000 leading enterprises. We have gathered more than a million institutional decision-makers and established strategic partnerships with over a thousand authoritative industry institutions. Shiyan Consulting adheres to the concept of professional development and has a team of over 100 senior professionals. The core management team has more than 15 years of professional experience.

Dr. Zhou Dandan from our company will replace Dr. Chen Dexiang as the guest speaker for this annual conference exchange.

Exploring Abroad on October 30th - Policy Prospects and Deepening Going Global

Guest lineup

Special Host: Zhang Jiguo, President of the Vaccine Division, Fosun Pharma

Opening Speech

Jerome Kim, Director General, International Vaccine Institute

Progress in Vaccine R&D Innovation and Regulatory Guidelines

Yang Yue, Researcher at the School of Pharmacy, Tsinghua University/Director of the Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration

Speech on the morning of October 31st

Moving towards Stability - Vaccine Process Optimization and Quality Control